According to GuruFocus list of 52-week highs, these guru stocks have reached their 52-week highs.
Exelon Corp. is a power retailer engaged in the utilities sector of the U.S. The company is involved in the power generation and transmission activities. The Generation segment generates maximum revenue for the company. Since acquiring Pepco in 2016, Exelon serves more customers than any other U.S. utility, with 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware and Washington, D.C. Exelon owns 11 nuclear plants and 33 gigawatts of generation capacity throughout North America, producing 20% of U.S. nuclear power and 5% of all U.S. electricity. The company is the largest power retailer in the U.S., serving about 200 terawatt-hours of load.
The price of Exelon Corp. shares has reached $51.95, which is 0.8% off the 52-week high of $52.36. Exelon Corp. has a market cap of $33.16 billion; its shares were traded around $51.95 with a price-earnings ratio of 11.40 and price-sales ratio of 1.20. The trailing 12-month dividend yield of Exelon Corp. stocks is 1.56%. The forward dividend yield of Exelon Corp. stocks is 6.26%. Exelon Corp. had an annual average earnings growth of 5.40% over the past five years.
Exelon Corp. recently reported its financial results for the third quarter of 2018. Exelon's GAAP net income for the third quarter of 2018 decreased to 76 cents per share from 85 cents per share in the third quarter of 2017. Adjusted operating earnings increased to 88 cents per share in the third quarter of 2018 from 85 cents per share in the third quarter of 2017. Adjusted operating earnings in the third quarter of 2018 primarily reflect higher electric distribution and energy efficiency earnings at ComEd, regulatory rate increases at PHI and favorable weather conditions at PECO and PHI.
Delhaize Group SA is a food retailing company. Its primary store format consists of food supermarkets. Its store network also includes other store formats such as proximity stores, cash and carry and specialty stores. Delhaize Group SA was founded in Belgium in 1867. It operates food supermarkets. Its conducts its retail operations through its businesses in the U.S.; Belgium and the Grand Duchy of Luxembourg, collectively as Delhaize Belgium; Greece, Romania and Serbia, collectively as Southeastern Europe; and Indonesia. Its store network also includes other store formats such as proximity, cash and carry and specialty stores.Â
The price of Delhaize Group SA shares has reached $28.11, which is 1.2% off the 52-week high of $28.45. Delhaize Group SA has a market cap of $11.67 billion; its shares were traded around $28.11. The trailing 12-month dividend yield of Delhaize Group SA stocks is 1.78%. The forward dividend yield of Delhaize Group SA stocks is 1.78%.
Ahold Delhaize recently reported a strong third quarter with improved sales across the board and strong growth of underlying operating income. Highlights include:
-Net sales of €15.8 billion, up 3.6% at constant exchange rates.
-U.S. comparable sales up 3.0% with positive volume growth.
-Net consumer online sales up 27.6% at constant exchange rates.
-Underlying operating margin of 4.1%, up 0.2% points, supported by synergies.
-Net income up 26.7% to €459 million, up 26.0% at constant exchange rates.
-Strong free cash flow of €538 million, up €112 million; full-year guidance raised to at least €2.0 billion.
Shire PLC is a biotechnology company focused mainly in the research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines for patients with rare diseases and other select conditions. Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
The price of Shire PLC shares has reached $179.20, which is 1.8% off the 52-week high of $182.47. Shire PLC has a market cap of $54.37 billion; its shares were traded around $179.20 with a price-earnings ratio of 12.10 and price-sales ratio of 3.70. The trailing 12-month dividend yield of Shire PLC stocks is 0.59%. The forward dividend yield of Shire PLC stocks is 0.59%. Shire PLC had an annual average earnings growth of 19.10% over the past 10 years. GuruFocus rated Shire PLCÂ the business predictability rank of 4-star.
Shire PLC recently announced unaudited results for the three months ended Sept. 30, 2018. Highlights include:
-Total revenues of $3.87 billion representing growth of 5%.
-Product sales increased 6% to $3.75 billion.
-Operating income increased 35% to $956 million.
-Non-GAAP operating income decreased 2% to $1.48 billion.
XL Group Ltd. provides insurance and reinsurance service. It provides property, casualty and specialty products to industrial, commercial and professional firms, insurance companies and other enterprises. With more than $10 billion of equity, XL is a significant player in the global insurance market. XL Insurance offers commercial and specialty insurance for risks, including satellites and horses. XL Re reinsures catastrophe, marine, and other risks. XL Financial guarantees investment contracts, designs structured weather-risk reinsurance products, and provides other specialty risk-management services, but XL is exiting some of these areas following recent stumbles.
The price of XL Group Ltd. shares has reached $57.37, which is 0.4% off the 52-week high of $57.60. XL Group Ltd. has a market cap of $14.85 billion; its shares were traded around $57.37 with and price-sales ratio of 1.31. The trailing 12-month dividend yield of XLGroup Ltd. stocks is 1.54%. The forward dividend yield of XL Group Ltd. stocks is 1.53%.
XL Group Ltd. recently reported its second quarter 2018 results. The company reported net income attributable to common shareholders of $319.0 million, or $1.21 per fully diluted share, for the quarter, compared to $301.6 million, or $1.14 per fully diluted share, in the prior year quarter. They also reported operating net income of $220.3 million, or 84 cents per fully diluted share, for the quarter, compared to $255.1 million, or 96 cents per fully diluted share, in the prior-year quarter.
Williams Partners LP is an energy infrastructure company that owns the Transco and Northwest natural gas pipelines. The firm owns and operates midstream gathering and processing assets, and interstate natural gas pipelines. It also produces olefins. Williams Partners is a large pipeline company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering and processing and storage assets. It also owns a 60% stake in Discovery, which owns offshore natural gas assets in the Gulf of Mexico. Williams Companies, a publicly traded C-Corporation, owns a 74% interest in Williams Partners. The partnership owns the underlying assets while the corporation holds the stake in the limited partnership.
The price of Williams Partners LP shares has reached $47.37, which is 1.6% off the 52-week high of $48.11. Williams Partners LP has a market cap of $46.26 billion; its shares were traded around $47.37 with a price-earnings ratio of 65.79 and price-sales ratio of 5.48. The trailing 12-month dividend yield of Williams Partners LP stocks is 5.16%. The forward dividend yield of Williams Partners LP stocks is 5.31%.
Williams Partners LP recently announced its financial results for the three and six months ended June 30, 2018. Williams Partners reported unaudited second-quarter 2018 net income attributable to controlling interests of $426 million, a $106 million improvement from second-quarter 2017. Year to date, Williams Partners reported unaudited net income of $786 million, a $168 million decrease from the same period in 2017. The company reported second-quarter 2018 adjusted Ebitda of $1.097 billion, a $7 million decrease from second-quarter 2017.
Note: I do not own the stocks discussed.